Hepatitis Weekly

Hepatitis C Virus Therapy - Researchers at Charite University target hepatitis C virus therapy

Hepatitis C Virus Therapy - Studies from University of Chicago, Center for Liver Diseases in the area of hepatitis C virus therapy published

Hepatitis C Virus Therapy - Studies from University of Colorado, Colorado Health Sciences Center further understanding of hepatitis C virus therapy

Hepatocellular Cancer Immunology - Investigators at Mount Sinai Medical Center zero in on hepatocellular cancer immunology

HIV/AIDS Co-Infection Immunology - New HIV/AIDS co-infection immunology research from University of California, Center for Comparative Medicine described

HIV/AIDS Prevention - Data from National Development and Research Institutes, Inc. advance knowledge in HIV/AIDS prevention

HIV/AIDS Therapy - Researchers at Londrina State University target HIV/AIDS therapy

Life Sciences - Reports outline life sciences study results from Johns Hopkins University, Department of Epidemiology

Liver Cancer - Reports outline liver cancer study findings from Cancer Council

Liver Disease - Study data from University of Duisburg-Essen, Department of Internal Medicine update understanding of liver disease

Alcoholism - New findings in alcoholism described from University of Foggia

Autoimmune Hemolytic Anemia - Studies from Gunma University provide new data on autoimmune hemolytic anemia

Coeliac Disease - Data on coeliac disease discussed by M.T. Ferro and colleagues

Hemochromatosis - New hemochromatosis study findings have been published by scientists at University of Bonn

Hepatitis - Data on hepatitis described by A. Shiryaeva et al

Hepatitis - New findings reported from Northeastern University describe advances in hepatitis

HIV/AIDS - New HIV/AIDS data have been reported by J.M. Leung and co-authors

Transfusion Medicine - Reports from Cairo University describe recent advances in transfusion medicine

Hepatitis Cell Biology - New hepatitis cell biology research from Columbia University discussed

Life Sciences - Findings from University of Iowa, Department of Microbiology provide new insights into life sciences

Life Sciences - Studies from S.H. Fang and colleagues reveal new findings on life sciences

Adverse Drug Reactions - Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)

Bioterrorism - Aethlon Medical to Pursue U.S. Government Biodefense Contract

Hepatitis B Virus - European Commission Approves Viread(R) for Chronic Hepatitis B

Hepatitis B Virus - Gilead Announces 72-Week Data From Two Pivotal Phase III Studies Evaluating Viread(R) for the Treatment of Chronic Hepatitis B

Hepatitis B Virus - Important Progress Toward Control of Hepatitis B and C

Hepatitis B Virus - Liver Diseases: a Huge European Health Burden, but Some Trends are Positive

Hepatitis C Virus - Pharmasset Adds Two Cohorts to R7128 Hepatitis C Study

Hepatitis C Virus - Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008

Hepatitis C Virus - Study shows positive findings in treating patients with advanced hepatitis C

Hepatitis C Virus - Vertex Announces Positive Interim Results with Telaprevir-based Therapy in Genotype 1 Chronic Hepatitis C Patients who Failed to Achieve SVR with Previous Pegylated Interferon & Ribavirin Treatment

HIV/AIDS - Number of HIV-Positive State and Federal Inmates Continues to Decline

Valeant Pharmaceuticals - Valeant Pharmaceuticals Highlights Taribavirin Phase IIb Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting